These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32910482)

  • 1. The delicate balance between neurotoxicity and neuroprotection in the context of HIV-1 infection.
    Sénécal V; Barat C; Tremblay MJ
    Glia; 2021 Feb; 69(2):255-280. PubMed ID: 32910482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing neuronal plasticity in NeuroAIDS: the experience of brain-derived neurotrophic factor and other neurotrophic factors.
    Mocchetti I; Bachis A; Campbell LA; Avdoshina V
    J Neuroimmune Pharmacol; 2014 Mar; 9(2):80-91. PubMed ID: 23832285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic dysfunction in human immunodeficiency virus type-1-positive subjects: inflammation or impaired neuronal plasticity?
    Avdoshina V; Bachis A; Mocchetti I
    J Intern Med; 2013 May; 273(5):454-65. PubMed ID: 23600400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Faceted Roles of Cocaine in Potentiation of HAND.
    Cai Y; Yang L; Callen S; Buch S
    Curr HIV Res; 2016; 14(5):412-416. PubMed ID: 27009095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration.
    Mamik MK; Asahchop EL; Chan WF; Zhu Y; Branton WG; McKenzie BA; Cohen EA; Power C
    J Neurosci; 2016 Oct; 36(41):10683-10695. PubMed ID: 27733618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy.
    Gill AJ; Kovacsics CE; Vance PJ; Collman RG; Kolson DL
    J Virol; 2015 Oct; 89(20):10656-67. PubMed ID: 26269184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-associated central nervous system dysfunction.
    Krebs FC; Ross H; McAllister J; Wigdahl B
    Adv Pharmacol; 2000; 49():315-85. PubMed ID: 11013768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis.
    Borrajo A; Spuch C; Penedo MA; Olivares JM; Agís-Balboa RC
    Ann Med; 2021 Dec; 53(1):43-69. PubMed ID: 32841065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.
    Mocchetti I; Bachis A; Avdoshina V
    Neurotox Res; 2012 Jan; 21(1):79-89. PubMed ID: 21948112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 infection and neurocognitive impairment in the current era.
    del Palacio M; Alvarez S; Muñoz-Fernández MÁ
    Rev Med Virol; 2012 Jan; 22(1):33-45. PubMed ID: 21990255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-associated neurological disorders: a guide to pharmacotherapy.
    Tan IL; McArthur JC
    CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.
    Han H; Yang Z; Chang SL; Li MD
    J Neuroimmune Pharmacol; 2018 Dec; 13(4):467-478. PubMed ID: 30215204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of fractalkine in HIV-1-infected astrocytes and consequences for the virus-related neurotoxicity.
    Sénécal V; Barat C; Gagnon MT; Vanasse F; Leboeuf M; Gosselin D; Tremblay MJ
    J Neurovirol; 2021 Apr; 27(2):279-301. PubMed ID: 33646495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Contribution of HIV-1 Subtypes B and C to Neurological Disorders: Mechanisms and Possible Treatments.
    Santerre M; Wang Y; Arjona S; Allen C; Sawaya BE
    AIDS Rev; 2019; 21(2):76-83. PubMed ID: 31332398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders.
    Fields J; Dumaop W; Langford TD; Rockenstein E; Masliah E
    J Neuroimmune Pharmacol; 2014 Mar; 9(2):102-16. PubMed ID: 24510686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of human immunodeficiency virus-induced neurodegeneration using isolated populations of human neurons, astrocytes, and microglia and neuroprotection mediated by insulin-like growth factors.
    Wang J; Gabuzda D
    J Neurovirol; 2006 Dec; 12(6):472-91. PubMed ID: 17162663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.